(Q52010935)

19 April 2018

title

Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease. (English)

1 reference

19 April 2018

1 reference

Sidransky E

1

1 reference

19 April 2018

Fartasch M

2

1 reference

19 April 2018

Lee RE

3

1 reference

19 April 2018

Metlay LA

4

1 reference

19 April 2018

Abella S

5

1 reference

19 April 2018

Zimran A

6

1 reference

19 April 2018

Gao W

7

1 reference

19 April 2018

Elias PM

8

1 reference

19 April 2018

Ginns EI

9

1 reference

19 April 2018

Holleran WM

10

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 January 1996

1 reference

19 April 2018

published in

Pediatric Research

1 reference

19 April 2018

volume

39

1 reference

19 April 2018

issue

1

1 reference

19 April 2018

page(s)

134-141

1 reference

19 April 2018

https://scigraph.springernature.com/pub.10.1203/00006450-199601000-00020

exact match

0 references

cites work

Clinical heterogeneity among patients with Gaucher's disease.

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

Cutaneous manifestations of Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

Collodion babies with Gaucher's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

Collodion babies with Gaucher's disease--a further case

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

Membrane structures in normal and essential fatty acid-deficient stratum corneum: characterization by ruthenium tetroxide staining and x-ray diffraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

Congenital ichthyosis preceding neurologic symptoms in two sibs with type 2 Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

Ichthyosis: mechanisms of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

Glucosylceramides stimulate murine epidermal hyperproliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

Barrier function regulates epidermal DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

DNA mutation analysis of Gaucher patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

A less costly regimen of alglucerase to treat Gaucher's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-199601000-00020

10.1203/00006450-199601000-00020

21 January 2018

Identifiers

DOI

1 reference

19 April 2018

Dimensions Publication ID

0 references

1 reference

19 April 2018